Polymorphism in PfMRP1 (Plasmodium falciparum multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine-pyrimethamine treatment.
about
Drug-resistant genotypes and multi-clonality in Plasmodium falciparum analysed by direct genome sequencing from peripheral blood of malaria patientsAntimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR NetworkThe interplay between drug resistance and fitness in malaria parasitesStructural polymorphism in the promoter ofpfmrp2confersPlasmodium falciparumtolerance to quinoline drugsWhole Genome Sequencing of Field Isolates Reveals Extensive Genetic Diversity in Plasmodium vivax from ColombiaNext-Generation Sequencing of Plasmodium vivax Patient Samples Shows Evidence of Direct Evolution in Drug-Resistance Genes.Anti-malarial treatment outcomes in Ethiopia: a systematic review and meta-analysisPlasmodium falciparum multidrug resistance protein 1 (pfmrp1) gene and its association with in vitro drug susceptibility of parasite isolates from north-east MyanmarWhole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genesWhole genome re-sequencing identifies a mutation in an ABC transporter (mdr2) in a Plasmodium chabaudi clone with altered susceptibility to antifolate drugs.Complex polymorphisms in the Plasmodium falciparum multidrug resistance protein 2 gene and its contribution to antimalarial response.The F423Y mutation in the pfmdr2 gene and mutations N51I, C59R, and S108N in the pfdhfr gene are independently associated with pyrimethamine resistance in Plasmodium falciparum isolates.Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reactionIn vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes.A Method for Amplicon Deep Sequencing of Drug Resistance Genes in Plasmodium falciparum Clinical Isolates from India.Multidrug ATP-binding cassette transporters are essential for hepatic development of Plasmodium sporozoites.Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.Antimalarial drugs: modes of action and mechanisms of parasite resistance.ABC transporters involved in drug resistance in human parasites.Dihydrofolate reductase as a therapeutic target for infectious diseases: opportunities and challenges.Membrane transport in the malaria parasite and its host erythrocyte.Unexpected selections of Plasmodium falciparum polymorphisms in previously treatment-naïve areas after monthly presumptive administration of three different anti-malarial drugs in Liberia 1976-78.MRP1 mediates folate transport and antifolate sensitivity in Plasmodium falciparum.Pyrosequencing: powerful and quantitative sequencing technology.
P2860
Q21091002-A4B9A5CD-8145-493A-9ABB-B0721FC9AAF5Q26799713-64583BCD-B1B7-48DC-A1C9-D29BC10022D9Q26998596-29FF09BF-EFFF-469D-A0F4-58AC5551FEADQ27861940-3EEF82ED-2129-4BF5-BE33-45D5214BC106Q28551791-05E70492-B51C-4D99-A6BE-2F4C5353B004Q30395320-DC5798AF-1164-4355-8A3E-BAC498C75DBAQ33869090-72F8054B-5E3C-4E99-8F82-7DD481236393Q33910002-CF3DE8C4-3532-434F-994A-8D93D2C792FDQ34359141-A0C26A0D-7E70-41F3-9F49-27045F953340Q34556998-052D3D58-88F1-45A3-B85A-1176ACDCAE2FQ34597342-668D8BC1-5B64-4AF0-BA92-137F147A3AA7Q35941471-BBDC0B39-FEFE-4D26-BA03-E06795E1F983Q35991544-63E55232-52D8-481A-A2E6-361621B4B842Q36757694-52A8CDA0-2868-48D2-A0FB-624C29D042A7Q36933131-4567AD23-DDE2-453B-9F76-880AB1990A77Q37173948-DBB870F3-1C57-4073-80AE-92643F72DF9DQ37544298-0CF4F4F0-8A49-4757-AA5A-96945D817510Q37820670-4F836E0E-65C7-4AD7-BE65-1C0B8967518DQ37941754-677B254D-B937-4A02-9304-BA499CB53F4BQ38026606-EDE09C33-3ADE-4AB4-90BC-C0B11B4F6064Q38170172-0C9FD106-F37B-4EE2-ADDC-44F864D4AE8AQ39112462-68557B13-EF94-442A-9D89-AD44AD7B913EQ40783005-D6EB14CD-894D-4DF7-832D-A7DEABBF7322Q44959680-4D020A39-76A9-468A-BABB-2BB062747B3E
P2860
Polymorphism in PfMRP1 (Plasmodium falciparum multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine-pyrimethamine treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polymorphism in PfMRP1 (Plasmo ...... oxine-pyrimethamine treatment.
@en
Polymorphism in PfMRP1
@nl
type
label
Polymorphism in PfMRP1 (Plasmo ...... oxine-pyrimethamine treatment.
@en
Polymorphism in PfMRP1
@nl
prefLabel
Polymorphism in PfMRP1 (Plasmo ...... oxine-pyrimethamine treatment.
@en
Polymorphism in PfMRP1
@nl
P2093
P2860
P921
P356
P1476
Polymorphism in PfMRP1 (Plasmo ...... doxine-pyrimethamine treatment
@en
P2093
Anders Björkman
Andreas Mårtensson
Sabina Dahlström
P2860
P304
P356
10.1128/AAC.00091-09
P407
P577
2009-04-13T00:00:00Z